These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35729018)

  • 1. The clinical value of circulating free tumor DNA in testicular germ cell tumor patients.
    Boublikova L; Kramarzova KS; Zwyrtkova M; Bakardjieva-Mihaylova V; Stuchly J; Rosova B; Kolostova K; Sonsky J; Kindlova E; Zachoval R; Buchler T; Trka J
    Urol Oncol; 2022 Sep; 40(9):412.e15-412.e24. PubMed ID: 35729018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of cfDNA in TGCT patient management: a systematic review.
    Krasic J; Skara L; Bojanac AK; Ulamec M; Jezek D; Kulis T; Sincic N
    Ther Adv Med Oncol; 2022; 14():17588359221090365. PubMed ID: 35656387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
    Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
    Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
    Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
    Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
    Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors.
    Klümper N; Syring I; Offermann A; Adler D; Vogel W; Müller SC; Ellinger J; Strauß A; Radzun HJ; Ströbel P; Brägelmann J; Perner S; Bremmer F
    Diagn Pathol; 2015 Sep; 10():165. PubMed ID: 26377566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular Pathogenesis of Testicular Germ Cell Tumors].
    Bakardjieva-Mihaylova V; Škvárová Kramarzová K; Slámová M; Büchler T; Boublíková L
    Klin Onkol; 2017; 30(6):412-419. PubMed ID: 29271211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling.
    Cools M; Wolffenbuttel KP; Hersmus R; Mendonca BB; Kaprová J; Drop SLS; Stoop H; Gillis AJM; Oosterhuis JW; Costa EMF; Domenice S; Nishi MY; Wunsch L; Quigley CA; T'Sjoen G; Looijenga LHJ
    Hum Reprod; 2017 Dec; 32(12):2561-2573. PubMed ID: 29121256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients.
    Ponti G; Maccaferri M; Manfredini M; Kaleci S; Mandrioli M; Pellacani G; Ozben T; Depenni R; Bianchi G; Pirola GM; Tomasi A
    Clin Chim Acta; 2018 Apr; 479():14-19. PubMed ID: 29309771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
    Chang Y; Wang X; Xu Y; Yang L; Qian Q; Ju S; Chen Y; Chen S; Qin N; Ma Z; Dai J; Ma H; Jin G; Zhang E; Wang C; Hu Z
    Cancer Med; 2019 Jul; 8(7):3511-3519. PubMed ID: 31070303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin.
    Belge G; Grobelny F; Radtke A; Bodes J; Matthies C; Wülfing C; Dieckmann KP
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):435-443. PubMed ID: 33200255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors.
    Hinz S; Magheli A; Weikert S; Schulze W; Krause H; Schrader M; Miller K; Kempkensteffen C
    World J Urol; 2010 Oct; 28(5):631-5. PubMed ID: 20043168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples.
    Huang Y; Mu J; Qi L; Ge W; Fang X; Song Y; Yuan Y; Zheng S
    Clin Chem Lab Med; 2020 Aug; 58(9):1451-1459. PubMed ID: 32229658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor.
    Guo J; Wang S; Jiang Z; Tang L; Liu Z; Cao J; Hu Z; Chen X; Luo Y; Bo H
    Front Immunol; 2022; 13():859730. PubMed ID: 35669771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of plasma cell-free DNA levels in dogs with various tumors.
    Tagawa M; Shimbo G; Inokuma H; Miyahara K
    J Vet Diagn Invest; 2019 Nov; 31(6):836-843. PubMed ID: 31585514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3 May Regulate Testicular Germ Cell Tumors Through EMT and Immune Pathways.
    Luo Y; Sun Y; Li L; Mao Y
    Cell Transplant; 2020; 29():963689720946653. PubMed ID: 32749150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and intensity of late effects in patients with testicular germ cell tumors: A first step of instrument development using a stepwise approach.
    Enzlin R; Vervoort SCJM; Suelmann BBM; Meijer RP; Teunissen SCCM; Zweers D
    Eur J Oncol Nurs; 2023 Jun; 64():102303. PubMed ID: 36931098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in Testicular Germ-Cell Tumor Patients.
    Svetlovska D; Miskovska V; Cholujova D; Gronesova P; Cingelova S; Chovanec M; Sycova-Mila Z; Obertova J; Palacka P; Rajec J; Kalavska K; Usakova V; Luha J; Ondrus D; Spanik S; Mardiak J; Mego M
    Clin Genitourin Cancer; 2017 Jun; 15(3):411-416.e2. PubMed ID: 28237180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.